Cargando…
Placeboxetine for major depressive disorder: Researcher, author, reader, and reviewer perspectives on randomized controlled trials
BACKGROUND: Postgraduate students, budding authors, clinicians who read journals, and new reviewers need to develop skills in reading, writing, and reviewing papers that describe randomized controlled trials (RCTs). MATERIALS AND METHODS: This commentary critically examines a specially-written paper...
Autor principal: | Andrade, Chittaranjan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056194/ https://www.ncbi.nlm.nih.gov/pubmed/21431014 http://dx.doi.org/10.4103/0019-5545.75553 |
Ejemplares similares
-
A 6-week, multicentre, randomized controlled clinical trial to evaluate the safety and efficacy of placeboxetine hydrochloride in the treatment of major depressive disorder in an Indian setting
por: Andrade, Chittaranjan
Publicado: (2011) -
How to write a good abstract for a scientific paper or conference presentation
por: Andrade, Chittaranjan
Publicado: (2011) -
Training in Post-authorization Pharmacovigilance
por: Ahuja, Vivek, et al.
Publicado: (2010) -
Trials and tribulations of clinical research teaching and training
por: Ghooi, Ravindra B.
Publicado: (2010) -
Open Access in Perspectives of Authors and Readers
por: Chung, Min Suk
Publicado: (2019)